CSI Market
Sign In | Register

Karuna Therapeutics Inc (KRTX) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access KRTX Annual Balance Sheets →
This balance sheet overview for Karuna Therapeutics Inc spans from Dec 31 2022 to Dec 31 2023, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Quarterly Report, GAAP in USD millions
ITEM 		(Dec 31 2023)
(Sep 30 2023) (Jun 30 2023) (Mar 31 2023) (Dec 31 2022)
Assets
Cash & cash equivalent185.82
Marketable Securities, Total MA1,074.96
Other Short-term Investments AS2.03
Cash & Short-term Investments1,261.00
Accounts receivable0.00
Deferred Offering Costs DE0.20
Other Current Assets0.00
Prepaid Expense And Other Assets Current39.99
Total Current Assets1,315.31
Equipment/Property/Plant Net8.53
Tax Assets, Noncurrent750.26
Other Assets, Noncurrent0.00
Restricted Cash Current0.10
Operating Lease Right Of Use Asset14.60
Total Assets1,336.21
Liabilities
Accounts Payable, Current AC6.78
Accrued Liabilities, Current AC41.61
Other Liabilities, Current0.00
Total Current Liabilities68.13
Total Long-term Debt0.00
Accrued Income Taxes, Noncurrent3.76
Other liabilities, Noncurrent0.00
OperatingLeaseLiabilityNoncurrent13.81
Operating Lease Liability Current1.80
Total Liabilities81.97
Stockholders' Equity
Aoci Before Tax Attributable To Parent-2.93
Common Stock Value0.00
Treasury Stock Value4.52
Additional Paid In Capital Common Stock2,256.43
Retained Earnings / Accumulated Deficit-997.89
Other Equity0.00
Common Stockholder's Equity1,254.24
Total Stockholder's Equity1,254.24
Liabilities & Stockholder's Equity1,336.21
4 historic quarters locked

Sign in to unlock the full Karuna Therapeutics Inc balance sheet history.

Sign In Create Free Account

About Karuna Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20231231)
  • Filed with the SEC: February 22, 2024
  • Source: krtx-20231231.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0000950170-24-018395

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.